Muraglitazar, a novel dual (&#945;/&#947;) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves &#946;-cell fuction in  db/db  mice

Thomas Harrity; Dennis Farrelly; Aaron Tieman; Cuixia Chu; Lori Kunselman; Liqun Gu; Randolph Ponticiello; Michael Cap; Fucheng Qu; Chunning Shao; Wei Wang; Hao Zhang; William Fenderson; Sean Chen; Pratik Devasthale; Yoon Jeon; Ramakrishna Seethala; Wen-Pin Yang; Jimmy Ren; Min Zhou; Denis Ryono; Scott Biller; Kasim A. Mookhtiar; John Wetterau; Richard Gregg; Peter T. Cheng; Narayanan Hariharan

Clinical Diabetology
Vol 7, No 1 (2006): Practical Diabetology Muraglitazar, a novel dual (α/γ) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves β-cell fuction in db/db mice

Vol 7, No 1 (2006): Practical Diabetology

Other materials agreed with the Editors

Published online: 2006-02-13

Page views 543

Article views/downloads 0

Get Citation

Connect on Social Media

Muraglitazar, a novel dual (α/γ) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves β-cell fuction in db/db mice

Thomas Harrity, Dennis Farrelly, Aaron Tieman, Cuixia Chu, Lori Kunselman, Liqun Gu, Randolph Ponticiello, Michael Cap, Fucheng Qu, Chunning Shao, Wei Wang, Hao Zhang, William Fenderson, Sean Chen, Pratik Devasthale, Yoon Jeon, Ramakrishna Seethala, Wen-Pin Yang, Jimmy Ren, Min Zhou, Denis Ryono, Scott Biller, Kasim A. Mookhtiar, John Wetterau, Richard Gregg, Peter T. Cheng, Narayanan Hariharan

Diabetologia Praktyczna 2006;7(1):16-29.

Abstract

Not available

Keywords: muraglitazardiabetes mellitusglucose toleranceadiponectin

Clinical Diabetology

About Via Medica Advertising

Bookstore (Ikamed) TVMed

News